JCJennifer Cohen

Jennifer Cohen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennifer Cohen has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study

    by David M. Barris, Lindsay R. Freud, Patrick E. Day, Shaine A. Morris, Keila N. Lopez, Ann Kavanaugh-McHugh, Stacy A.S. Killen, Shabnam Peyvandi, Flora Nuñez Gallegos, Anita J. Moon-Grady, et al.

    BACKGROUND: Hypoplastic left heart syndrome (HLHS) is classified by anatomic subtype: mitral atresia and aortic atresia (MA/AA), mitral stenosis and aortic atresia (MS/AA), and mitral stenosis and aortic stenosis (MS/AS). The MS/AA subtype is associated with ventriculocoronary connections (VCCs). We assessed whether specific HLHS subtypes are associated with an increased risk of mortality and whether this risk is stratified by VCCs identified during fetal or postnatal echocardiography. We also assessed whether the type of neonatal intervention performed modified the risk. METHODS: We performed a multicenter retrospective cohort study of fetuses and infants P =0.784). CONCLUSIONS: In a large, multicenter cohort of HLHS patients, the MS/AA subtype with VCCs had the lowest TFS. Prenatal diagnosis of VCCs was associated with a lower TFS. This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

  • Proposed resources required for a comprehensive program for CCT CHD imaging

    by B. Kelly Han, Cynthia K. Rigsby, Tarique Hussain, Anthony Hlavacek, Anjali Chelliah, Kanwal M. Farooqi, Jennifer Cohen, Timothy Slesnick, Rajesh Krishnamurthy, Taylor Chung, et al.


  • Tetralogy of Fallot

    by Robert H. Pass, Jennifer Cohen


  • Tetralogy of Fallot

    by Robert H. Pass, Jennifer Cohen


  • Open Access

    Congenitally Corrected Transposition of the Great Arteries: Fetal Diagnosis, Associations, and Postnatal Outcome: A Fetal Heart Society Research Collaborative Study

    by Jennifer Cohen, Bhawna Arya, Richard Caplan, Mary T. Donofrio, Dina Ferdman, Jamie K. Harrington, Deborah Y. Ho, Whitnee Hogan, Lisa K. Hornberger, Simone Jhaveri, et al.

    Background: Fetal diagnosis of congenitally corrected transposition of the great arteries (ccTGA) has been increasingly reported; however, predictors of clinical outcomes remain underexplored. We undertook a multicenter, retrospective study to investigate natural history, associated anomalies, and outcomes of fetal ccTGA. Methods and Results: Fetuses with ccTGA diagnosed from January 2004 to July 2020 within 20 North American programs were included. Fetuses with severe ventricular hypoplasia thought to definitively preclude biventricular repair were excluded. We included 205 fetuses diagnosed with ccTGA at a median gestational age of 23 (interquartile range, 21–27) weeks. Genetic abnormalities were found in 5.9% tested, with extracardiac anomalies in 6.3%. Associated cardiac defects were diagnosed in 161 (78.5%), with atrioventricular block in 23 (11.3%). On serial fetal echocardiogram, 39% demonstrated a functional or anatomic change, most commonly increased tricuspid regurgitation (6.7%) or pulmonary outflow obstruction (11.1%). Of 194 fetuses with follow‐up, 26 were terminated, 3 experienced fetal death (2 with atrioventricular block), and 165 were live‐born. Of 158 with postnatal data (median follow‐up 3.7 years), 10 (6.6%) had death/transplant before 1 year. On univariable analysis, fetal factors associated with fetal death or death/transplant by 1 year included ≥ mild tricuspid regurgitation, pulmonary atresia, aortic obstruction, fetal arrhythmia, and worsening hemodynamics on serial fetal echocardiogram (defined as worse right ventricular function, tricuspid regurgitation, or effusion). Conclusions: Associated cardiac lesions and arrhythmias are common in fetal ccTGA, and functional changes commonly occur through gestation. Worse outcomes are associated with fetal tricuspid regurgitation (≥mild), any arrhythmia, pulmonary atresia, aortic obstruction, and worsening hemodynamics on serial echocardiograms. These findings can inform prenatal counseling and perinatal management planning.


  • Open Access

    Prediction of postnatal circulation in pulmonary atresia/critical stenosis with intact ventricular septum: systematic review and external validation of models

    by C. Villalaín, A. J. Moon‐Grady, U. Herberg, J. Strainic, J. L. Cohen, A. Shah, D. S. Levi, E. Gómez‐Montes, I. Herraiz, A. Galindo

    Objective: A favorable postnatal prognosis in cases of pulmonary atresia/critical stenosis with intact ventricular septum (PA/CS‐IVS) is generally equated with the possibility of achieving biventricular (BV) repair. Identification of fetuses that will have postnatal univentricular (UV) circulation is key for prenatal counseling, optimization of perinatal care and decision‐making regarding fetal therapy. We aimed to evaluate the accuracy of published models for predicting postnatal circulation in PA/CS‐IVS using a large internationally derived validation cohort.Methods: This was a systematic review of published uni‐ and multiparametric models for the prediction of postnatal circulation based on echocardiographic findings at between 20 and 28 weeks of gestation. Models were externally validated using data from the International Fetal Cardiac Intervention Registry. Sensitivity, specificity, predictive values, area under the receiver‐operating‐characteristics curves (AUCs) and proportion of cases with true vs predicted outcome were calculated.Results: Eleven published studies that reported prognostic parameters of postnatal circulation were identified. Models varied widely in terms of the main outcome (UV (n = 3), non‐BV (n = 3), BV (n = 3), right‐ventricle‐dependent coronary circulation (n = 1) or tricuspid valve size at birth (n = 1)) and in terms of the included predictors (single parameters only (n = 6), multiparametric score (n = 4) or both (n = 1)), and were developed on small sample sizes (range, 15–38). Nine models were validated externally given the availability of the required parameters in the validation cohort. Tricuspid valve diameter Z‐score, tricuspid regurgitation, ratios between right and left cardiac structures and the presence of ventriculocoronary connections (VCC) were the most commonly evaluated parameters. Multiparametric models including up to four variables (ratios between right and left structures, right ventricular inflow duration, presence of VCC and tricuspid regurgitation) had the best performance (AUC, 0.80–0.89). Overall, the risk of UV outcome was underestimated and that of BV outcome was overestimated by most models.Conclusions: Current prenatal models for the prediction of postnatal outcome in PA/CS‐IVS are heterogeneous. Multiparametric models for predicting UV and non‐BV circulation perform well in identifying BV patients but have low sensitivity, underestimating the rate of fetuses that will ultimately have UV circulation. Until better discrimination can be achieved, fetal interventions may need to be limited to only those cases in which non‐BV postnatal circulation is certain. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    Targeted Therapy for Pulmonary Hypertension in Premature Infants

    by Shannon N. Nees, Erika B. Rosenzweig, Jennifer L. Cohen, Gerson A. Valencia Villeda, Usha S. Krishnan

    Pulmonary hypertension (PH) is common in premature infants with bronchopulmonary dysplasia (BPD) and is associated with significant mortality. Despite expert consensus suggesting the use of targeted therapies such as phosphodiesterase inhibitors, endothelin receptor antagonists, and prostanoids, there is little data on safety and outcomes in infants with BPD-associated PH (BPD-PH) treated with these medications. We sought to describe the pharmacologic management of BPD-PH and to report outcomes at our institution. Premature infants with BPD-PH born between 2005 and 2016 were included. Follow-up data were obtained through January 2020. A total of 101 patients (61 male, 40 female) were included. Of these, 99 (98.0%) patients were treated with sildenafil, 13 (12.9%) with bosentan, 35 (34.7%) with inhaled iloprost, 12 (11.9%) with intravenous epoprostenol, and nine (8.9%) with subcutaneous treprostinil. A total of 33 (32.7%) patients died during the study period and 10 (9.9%) were secondary to severe to pulmonary hypertension. Of the surviving patients, 57 (83.8%) had follow-up data at a median of 5.1 (range 0.38–12.65) years and 44 (77.2%) were weaned off PH medications at a median 2.0 (range 0–8) years. Mortality for BPD-PH remains high mostly due to co-morbid conditions. However, for those patients that survive to discharge, PH therapies can frequently be discontinued in the first few years of life.


  • Fetal cardiac findings and hemodynamic changes associated with severe lower urinary tract obstruction in utero

    by Jennifer Cohen, Stéphanie Levasseur, Lynn Simpson, Russell Miller, Lindsay Freud

    Objectives: To describe fetal echocardiographic findings associated with lower urinary tract obstruction (LUTO) and to compare anatomic and hemodynamic measurements between fetuses with LUTO and gestational age (GA)‐matched controls, with an emphasis on quantitative indices of diastolic function and cardiac output.Methods: This was a retrospective cohort study of fetuses diagnosed with severe LUTO with giant bladder, which underwent at least one fetal echocardiogram at our center between January 2005 and June 2018. Fetuses with major congenital heart disease were excluded. Control fetuses did not have any structural or functional abnormalities and were GA‐matched to the LUTO fetuses based on the time of the first fetal echocardiogram. Cardiac anatomy and hemodynamic measurements were compared between fetuses with LUTO and controls. In infants with LUTO, serial fetal and postnatal echocardiographic data were assessed, when available, and clinical outcomes were reviewed.Results: Twenty‐six fetuses with LUTO and at least one fetal echocardiogram available were identified, one of which was excluded due to hypoplastic left heart syndrome, leaving 25 LUTO fetuses in the final cohort. The mean GA at the first fetal echocardiogram was 25.4 ± 5.1 weeks in the LUTO group and 25.3 ± 5.0 weeks in the control group. Common findings in fetuses with LUTO included cardiomegaly (40%), pericardial effusion (44%), right ventricular (RV) hypertrophy (64%) and left ventricular (LV) hypertrophy (48%). Compared with GA‐matched controls, LUTO fetuses had lower ascending aorta Z‐score (−0.10 ± 0.94 vs −0.93 ± 1.03; P = 0.02) and aortic isthmus Z‐score (−0.14 ± 0.86 vs −1.62 ± 1.11; P < 0.001), shorter mitral valve inflow time indexed to cardiac cycle length (0.46 ± 0.04 vs 0.41 ± 0.06; P = 0.002), and worse (increased) LV myocardial performance index (0.39 ± 0.03 vs 0.44 ± 0.04; P < 0.001). In addition, the ratio of RV to LV cardiac index was higher in LUTO fetuses compared with controls (1.62 ± 0.13 vs 1.33 ± 0.11; P < 0.001). Of the 25 LUTO pregnancies, two were lost to follow‐up, three underwent elective termination of pregnancy and three ended in intrauterine fetal demise. Four (16%) patients had mildly hypoplastic left‐heart structures, comprising two with aortic arch hypoplasia and two with mitral and aortic stenosis.Conclusion: In addition to presenting with cardiomegaly, pericardial effusion and ventricular hypertrophy, fetuses with LUTO demonstrate LV diastolic dysfunction and appear to redistribute cardiac output as compared to control fetuses, which may contribute to the development of left‐heart hypoplasia. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.


  • Myocardial strain abnormalities in fetuses with pulmonary atresia and intact ventricular septum

    by Jennifer Cohen, Edem Binka, Kristal Woldu, Stéphanie Levasseur, Julie Glickstein, Lindsay R. Freud, Anjali Chelliah, Joanne S. Chiu, Amee Shah

    Objectives: Global and regional myocardial deformation have not been well described in fetuses with pulmonary atresia and intact ventricular septum (PA/IVS). Speckle‐tracking echocardiography (STE), an angle‐independent technique for assessing global and regional strain, may be a more sensitive way of determining ventricular systolic dysfunction compared with traditional 2D echocardiography. The aim of this study was to assess myocardial deformation in fetuses with PA/IVS compared with control fetuses and to determine if, in fetuses with PA/IVS, strain differs between those with and those without right ventricle‐dependent coronary circulation (RVDCC).Methods: This was a retrospective analysis of fetuses with PA/IVS examined at two medical centers between June 2005 and October 2017. Left ventricular (LV) and right ventricular (RV) regional and global longitudinal strain (GLS) and strain rate were obtained using STE, and comparisons were made between fetuses with PA/IVS and gestational age (GA)‐matched controls. Postnatal outcome was assessed, including the presence of RVDCC.Results: Fifty‐seven fetuses with PA/IVS and 57 controls were analyzed at a mean GA of 26.5 ± 5 weeks. LV‐GLS was significantly decreased in fetuses with PA/IVS compared with controls (−17.4 ± 1.7% vs −23.7 ± 2.0%, P < 0.001). LV strain rate was also significantly decreased (−1.01 ± 0.21/s vs −1.42 ± 0.20/s, P < 0.001). Fetuses with PA/IVS had decreased strain in all segments. Similarly, RV strain was significantly decreased in fetuses with PA/IVS (−11.6 ± 3.8% vs −24.6 ± 2.5%, P < 0.0001). Thirty‐six patients had postnatal cardiac catheterization performed to define coronary anatomy; 10 fetuses had RVDCC. Fetuses with RVDCC had decreased LV strain compared with those without (−15.8 ± 1.2% vs −17.9 ± 1.7%, P = 0.009). RV strain was also decreased in fetuses with RVDCC vs those without (−7.0 ± 2.9% vs −12.1 ± 3.2%, P = 0.0004).Conclusions: Fetuses with PA/IVS have decreased global and regional LV and RV strain compared with controls. The finding of decreased LV strain may be due to altered ventricular mechanics in the context of a hypertensive right ventricle and/or abnormal coronary perfusion. Moreover, fetuses that were found to have RVDCC postnatally had decreased LV and RV strain compared with those that did not. These results encourage further investigation to assess whether fetal ventricular strain could be a prenatal predictor of RVDCC. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.


  • Sildenafil Use in Children with Pulmonary Hypertension

    by Jennifer L. Cohen, Shannon N. Nees, Gerson A. Valencia, Erika B. Rosenzweig, Usha S. Krishnan